pharma · Epilepsy · Allergic Reaction · AQST
Aquestive Therapeutics
Aquestive Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker AQST. Primary therapeutic focus areas include Epilepsy, Allergic Reaction, Nausea and Vomiting, Postoperative
Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Founded
- 2009
- Employees
- 75
- Programs
- 9
- Drugs
- 9
- Patents
- 17
42-1703
Phase 3 · small molecule · Epilepsy
42-1703 for Epilepsy is a Phase 3 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code 42-1703
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aquestive Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Epilepsy
- Status
- completed
- Trials
- 1